Aaron K. Joseph
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Aaron K. Joseph has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Heather L. Anderson
Baylor College of Medicine, Houston, Texas
3 shared publicationsCurt Mueller
Walsh Center for Rural Health Analysis, Project Hope, Bethesda, Maryland
2 shared publicationsTami L. Mark
MEDSTAT Group, Research and Policy Division, Washington, D.C.
2 shared publicationsHeather L. Ba Anderson
Baylor College of Medicine, Houston, Texas
1 shared publicationMelissa A Bogle
1 shared publicationMelissa A. Bogle
Department of Dermatology, The University of Texas and M.D. Anderson Cancer Center, Houston, Texas, USA
1 shared publication
Latest Publications
- 1 February 2013
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 39 (2) , 315-316
Commentary: Nail Avulsion Before Nail Surgery: Is It Always Necessary?
- 1 February 2013
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 39 (2) , 315-316
Commentary: Nail Avulsion Before Nail Surgery: Is It Always Necessary?
- 1 January 2011
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 37 (1) , 80-81
Commentary: Nasal Island Pedicle Flaps: Is Partial Wound Coverage Enough?
- 1 January 2011
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 37 (1) , 80-81
Commentary: Nasal Island Pedicle Flaps: Is Partial Wound Coverage Enough?
- 1 November 2008
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 21 (6) , 459-466
Sebaceous carcinoma: the great masquerader
Sebaceous carcinoma (SC) is a rare tumor with a high rate of local recurrence and metastasis to lymph nodes and organs. The majority of SCs occur in the periocular region frequently presenting as painless, round subcutaneous nodules with a high tendency of diffuse and invasive growth in the eyelid and conjunctiva. It frequently masquerades as inflammatory conditions or as other tumors leading to delay in diagnosis, inappropriate treatment and increased morbidity and mortality. Sebaceous carcinoma is associated with Muir-Torre syndrome, a genetic condition presenting with sebaceous skin tumors associated with internal malignancy. Therefore, SC patients must be carefully evaluated and referred to an internist or gastroenterologist when indicated. Surgery is the definitive therapy for SC. In recent years, less radical surgical strategies are being used with improved outcomes. Current studies demonstrate that Mohs micrographic surgery (MMS) provides maximal tissue conservation and lower recurrence rates. Greater awareness and understanding of SC and its behavior has led to earlier diagnosis and appropriate treatment.
- 1 November 2008
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 21 (6) , 459-466
Sebaceous carcinoma: the great masquerader
Sebaceous carcinoma (SC) is a rare tumor with a high rate of local recurrence and metastasis to lymph nodes and organs. The majority of SCs occur in the periocular region frequently presenting as painless, round subcutaneous nodules with a high tendency of diffuse and invasive growth in the eyelid and conjunctiva. It frequently masquerades as inflammatory conditions or as other tumors leading to delay in diagnosis, inappropriate treatment and increased morbidity and mortality. Sebaceous carcinoma is associated with Muir-Torre syndrome, a genetic condition presenting with sebaceous skin tumors associated with internal malignancy. Therefore, SC patients must be carefully evaluated and referred to an internist or gastroenterologist when indicated. Surgery is the definitive therapy for SC. In recent years, less radical surgical strategies are being used with improved outcomes. Current studies demonstrate that Mohs micrographic surgery (MMS) provides maximal tissue conservation and lower recurrence rates. Greater awareness and understanding of SC and its behavior has led to earlier diagnosis and appropriate treatment.
- 1 July 2008
- Published by California Digital Library (CDL) in Dermatology Online Journal
- Vol. 14 (7) , 8
Brooke-Spiegler Syndrome: Report of a case of multiple cylindromas and trichoepitheliomas
Author(s): Doherty, Sean D; Barrett, Terry L; Joseph, Aaron K
- 1 July 2008
- Published by California Digital Library (CDL) in Dermatology Online Journal
- Vol. 14 (7) , 8
Brooke-Spiegler Syndrome: Report of a case of multiple cylindromas and trichoepitheliomas
Author(s): Doherty, Sean D; Barrett, Terry L; Joseph, Aaron K
- 1 June 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (6) , 693-696
A Pilot Feasibility Study of a Rare Skin Tumor Database
BACKGROUND In the United States melanoma is the only individually reported skin cancer. There are no large state or national registries for nonmelanoma skin cancer. Nevertheless, rare, that is, nonmelanoma, nonepithelial, tumors can also be locally aggressive and metastasize. OBJECTIVES This study's purpose was to demonstrate that Mohs surgeons can share data to create a rare skin tumor database. This database may serve as a model for a nationwide database. MATERIALS AND METHODS We retrospectively reviewed the surgery logs of five Mohs surgery practices in the Houston, Texas, area for rare—nonmelanoma, nonepithelial—skin cancers. A total of 42,279 biopsy-proven cancers of the skin treated with Mohs micrographic surgery were reviewed. Tumor data including type, prevalence, year of treatment, and the treating Mohs surgeon(s) were compiled and analyzed. RESULTS Forty-three types of rare tumors were identified. A total of 317 rare tumors were treated. No practice saw more than 28 rare tumor types. Atypical fibroxanthoma was the rare tumor most often treated. CONCLUSIONS Colleagues can cooperate to create a database of rare tumors removed by Mohs micrographic surgery. A range of tumors greater than that seen in any single practice is now available for study. This should provide the impetus for a nationwide rare skin tumor database.
- 1 June 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (6) , 693-696
A Pilot Feasibility Study of a Rare Skin Tumor Database
BACKGROUND In the United States melanoma is the only individually reported skin cancer. There are no large state or national registries for nonmelanoma skin cancer. Nevertheless, rare, that is, nonmelanoma, nonepithelial, tumors can also be locally aggressive and metastasize. OBJECTIVES This study's purpose was to demonstrate that Mohs surgeons can share data to create a rare skin tumor database. This database may serve as a model for a nationwide database. MATERIALS AND METHODS We retrospectively reviewed the surgery logs of five Mohs surgery practices in the Houston, Texas, area for rare—nonmelanoma, nonepithelial—skin cancers. A total of 42,279 biopsy-proven cancers of the skin treated with Mohs micrographic surgery were reviewed. Tumor data including type, prevalence, year of treatment, and the treating Mohs surgeon(s) were compiled and analyzed. RESULTS Forty-three types of rare tumors were identified. A total of 317 rare tumors were treated. No practice saw more than 28 rare tumor types. Atypical fibroxanthoma was the rare tumor most often treated. CONCLUSIONS Colleagues can cooperate to create a database of rare tumors removed by Mohs micrographic surgery. A range of tumors greater than that seen in any single practice is now available for study. This should provide the impetus for a nationwide rare skin tumor database.
- 1 June 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (6) , 693-696
A Pilot Feasibility Study of a Rare Skin Tumor Database
In the United States melanoma is the only individually reported skin cancer. There are no large state or national registries for nonmelanoma skin cancer. Nevertheless, rare, that is, nonmelanoma, nonepithelial, tumors can also be locally aggressive and metastasize. This study's purpose was to demonstrate that Mohs surgeons can share data to create a rare skin tumor database. This database may serve as a model for a nationwide database. We retrospectively reviewed the surgery logs of five Mohs surgery practices in the Houston, Texas, area for rare-nonmelanoma, nonepithelial-skin cancers. A total of 42,279 biopsy-proven cancers of the skin treated with Mohs micrographic surgery were reviewed. Tumor data including type, prevalence, year of treatment, and the treating Mohs surgeon(s) were compiled and analyzed. Forty-three types of rare tumors were identified. A total of 317 rare tumors were treated. No practice saw more than 28 rare tumor types. Atypical fibroxanthoma was the rare tumor most often treated. Colleagues can cooperate to create a database of rare tumors removed by Mohs micrographic surgery. A range of tumors greater than that seen in any single practice is now available for study. This should provide the impetus for a nationwide rare skin tumor database.
- 1 June 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (6) , 693-696
A Pilot Feasibility Study of a Rare Skin Tumor Database
In the United States melanoma is the only individually reported skin cancer. There are no large state or national registries for nonmelanoma skin cancer. Nevertheless, rare, that is, nonmelanoma, nonepithelial, tumors can also be locally aggressive and metastasize. This study's purpose was to demonstrate that Mohs surgeons can share data to create a rare skin tumor database. This database may serve as a model for a nationwide database. We retrospectively reviewed the surgery logs of five Mohs surgery practices in the Houston, Texas, area for rare-nonmelanoma, nonepithelial-skin cancers. A total of 42,279 biopsy-proven cancers of the skin treated with Mohs micrographic surgery were reviewed. Tumor data including type, prevalence, year of treatment, and the treating Mohs surgeon(s) were compiled and analyzed. Forty-three types of rare tumors were identified. A total of 317 rare tumors were treated. No practice saw more than 28 rare tumor types. Atypical fibroxanthoma was the rare tumor most often treated. Colleagues can cooperate to create a database of rare tumors removed by Mohs micrographic surgery. A range of tumors greater than that seen in any single practice is now available for study. This should provide the impetus for a nationwide rare skin tumor database.
- 1 February 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (2) , 245-248
Hypertension in the Preoperative Evaluation
- 1 February 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (2) , 245-248
Hypertension in the Preoperative Evaluation
- 1 February 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (2) , 245-248
Hypertension in the Preoperative Evaluation: Report of Four Cases and Review of the Literature
- 1 February 2007
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 33 (2) , 245-248
Hypertension in the Preoperative Evaluation: Report of Four Cases and Review of the Literature
- 1 February 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (2) , 231-233
Mohs Micrographic Surgery for the Eradication of Phaeohyphomycosis of the Hand
Phaeohyphomycosis is a rare mycotic infection that is caused by dematiaceous fungi requiring surgical excision or long-term use of oral antifungal agents for treatment. To report a case of phaeohyphomycosis of the dorsal hand successfully cleared with Mohs micrographic surgery. We performed Mohs micrographic surgery on phaeohyphomycosis of the dorsal hand. The fungus was cleared in three stages of surgery. Permanent processing and special stains of the final stage confirmed eradication of the infection. The patient remained free of the phaeohyphomycosis, without complications, at the 6-month follow-up. Mohs micrographic surgery is an effective, tissue-sparing technique for the eradication of phaeohyphomycosis, potentially eliminating the need for costly long-term antifungal therapy.
- 1 February 2004
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 30 (2) , 231-233
Mohs Micrographic Surgery for the Eradication of Phaeohyphomycosis of the Hand
Phaeohyphomycosis is a rare mycotic infection that is caused by dematiaceous fungi requiring surgical excision or long-term use of oral antifungal agents for treatment. To report a case of phaeohyphomycosis of the dorsal hand successfully cleared with Mohs micrographic surgery. We performed Mohs micrographic surgery on phaeohyphomycosis of the dorsal hand. The fungus was cleared in three stages of surgery. Permanent processing and special stains of the final stage confirmed eradication of the infection. The patient remained free of the phaeohyphomycosis, without complications, at the 6-month follow-up. Mohs micrographic surgery is an effective, tissue-sparing technique for the eradication of phaeohyphomycosis, potentially eliminating the need for costly long-term antifungal therapy.